Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,421 public trials 1,034 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Open-label Study of IMGN779 in Adult Patients With Relapsed/Refractory CD33-positive Acute Myeloid Leukemia

NCT02674763

Conditions: Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations: Comprehensive Cancer Center (UAB CCC) Birmingham, Alabama, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

New Mexico Cancer Care Alliance Albuquerque, New Mexico, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])

NCT00179764

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +33 more
Locations: Lurie Children's Hospital Chicago, Illinois, United States

View Trial Details

Completed

Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML

NCT02474290

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hematopoietic Stem Cell Transplantation, +6 more
Locations: Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Completed

Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

NCT00474929

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +44 more
Locations: Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

View Trial Details

Completed

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL)

NCT01675102

Conditions: CLL, Chromosome 17 deletion, Chronic Disease, +15 more
Locations: Rigshospitalitet Copenhagen, Denmark

University Central Hospital Helsinki, Finland

Universitaetsklinikum Dresden, Germany

University Hospital Eppendorf Hamburg, Germany

View Trial Details

Completed

Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy

NCT01519596

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +15 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Completed

A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT02556892

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Fukuoka, Japan

Hiroshima, Japan

Isehara, Japan

Kobe, Japan

View Trial Details

Completed

Pain at Home After Tonsillectomy With or Without Adenoidectomy

NCT03378830

Conditions: Adenotonsillectomy, Apnea, Dyssomnias, +23 more
Locations: The Montreal Children's Hospital Montreal, Quebec, Canada

View Trial Details

Completed

Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

NCT00382109

Conditions: B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease, +15 more
Locations: Phoenix Childrens Hospital Phoenix, Arizona, United States

City of Hope Medical Center Duarte, California, United States

Children's Hospital and Research Center at Oakland Oakland, California, United States

Childrens Hospital of Orange County Orange, California, United States

View all 50 locations

View Trial Details

Completed

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01839916

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +134 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Leukemia

Leukemia trial results

Related conditions